Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1992-11-02
1994-06-21
McMahon, Timothy M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
435101, 4352552, 536114, 536121, 536123, 536124, 53612312, A61K 31715
Patent
active
053228413
ABSTRACT:
A method for producing soluble preparations of neutral glucan polymers is disclosed. The method involves treating whole glucan particles with a unique sequence or acid and alkaline treatments to produce soluble glucan. The soluble glucan can be purified to obtain a physiologically acceptable solution of neutral glucan molecules. A soluble neutral glucan preparation is obtained which forms a clear solution at a neutral pH and is equilibrated in a pharmaceutically acceptable carrier.
REFERENCES:
patent: 4138479 (1979-02-01), Truscheit et al.
patent: 4237266 (1980-12-01), Sugiura et al.
patent: 4739046 (1988-04-01), DiLuzio et al.
patent: 4761402 (1988-08-01), Williams et al.
patent: 4810646 (1989-03-01), Jamas et al.
patent: 5032401 (1991-07-01), Jamas et al.
patent: 5057503 (1991-10-01), Czop et al.
Manners et al., Biochem. J. (1973), vol. 135, pp. 19-30.
Shiota et al., J. Biochem. (1985), vol. 98, pp. 1301-1307.
Konopski et al., "Phagocytosis of .beta.-1,3-D-Glucan-Derivatized Microbeads by Mouse Peritoneal Macrophages Involves Three Different Receptors," Scand. J. Immunol. 33: 297-306 (1991).
Julia B. Reiskind and J. T. Mullins, "Molecular Architecture of the Hyphal wall of Achlya ambisexualis Raper. II. Ultrastructural Analyses and a Proposed Modell," Can. J. Microbiol. 27: 1100-1105 (1981).
Miyazaki et al., "Structural Examination of Antitumour, Water-Soluble Glucans from Grifora umbellata By Use of Four Types of Glucanase," Carbohydrate Research 65: 235-243 (1978).
G. H. Fleet and D. J. Manners, "Isolation and Composition of an Alkali-Soluble Glucan from the Cell Walls of Saccharomyces cerevisiae," Journal of General Microbiology 94: 180-192 (1976).
Latge' et al., "Composition Chimique et Ultrastructure des parois des corps hyphaux et des azygospores de Conidiobolus obscurus," Can. J. Microbiol. 30: 1507-1521 (1984).
Hara et al., "A Branched (1-3)-.beta.-D-Glucan From a Water Extact of Dictyophora indusiata FISCH," Carbohydrate Research 145: 237-246 (1986).
R. Goldman, "Induction of a .beta.-1,3-D-glucan receptor in P388D1 cells treated with retinoic acid or 1,25-dihydroxyvitamin D.sub.3," Immunology 63: 319-324 (1988).
Sherwood et al., "Soluble Glucan and Lymphokine-Activated Killer (LAK) Cells in the Therapy of Experimental Hepatic Metastases," Chemical Abstracts 108: 179752v (1988).
Janusz, M. J. et al., J. Immunol. 137: 3270-3276 (Nov. 15, 1986).
Manners, D. J. et al., Biochem. J. 135: 19-30 )1973).
Williams, D. L. et al., Chemical Abstracts 109: 66566q (1988).
Fleet, G. H. et al., Chemical Abstracts 85: 89819z (1976).
Bacon, J. et al., Biochem. J. 114: 557-567 (1969).
International Search Report for PCT/US90/05041 which claims priority to the subject application.
Easson, Jr. D. Davidson
Jamas Spiros
Ostroff Gary R.
Alpha-Beta Technology, Inc.
McMahon Timothy M.
LandOfFree
Method for producing neutral glucans for pharmaceutical applicat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for producing neutral glucans for pharmaceutical applicat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing neutral glucans for pharmaceutical applicat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2220757